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MiR-21 Induced Angiogenesis through AKT and ERK
Activation and HIF-1a Expression
Ling-Zhi Liu1,2, Chongyong Li1, Qi Chen1, Yi Jing2, Richard Carpenter2, Yue Jiang2, Hsiang-Fu Kung3,
Lihui Lai4, Bing-Hua Jiang1,2*
1 Lab of Reproductive Medicine, Department of Pathology, Cancer Center, Nanjing Medical University, Nanjing, Jiangsu, China, 2 Department of Pathology, Anatomy and
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of Hong Kong, Hong Kong, China, 4 Institute of Molecular and Chemical Biology, East China Normal University, Shanghai, China

Abstract
MicroRNAs (miRNAs) are endogenous, small noncoding RNAs that play important roles in various cellular functions and
tumor development. Recent studies have indicated that miR-21 is one of the important miRNAs associated with tumor
growth and metastasis, but the role and molecular mechanism of miR-21 in regulating tumor angiogenesis remain to be
elucidated. In this study, miR-21 was overexpressed by transfecting pre-miR-21 into human prostate cancer cells and tumor
angiogenesis was assayed using chicken chorioallantoic membrane (CAM). We found that overexpression of miR-21 in
DU145 cells increased the expression of HIF-1a and VEGF, and induced tumor angiogenesis. AKT and extracellular regulated
kinases (ERK) 1/2 are activated by miR-21. Inhibition of miR-21 by the antigomir blocked this process. Overexpression of the
miR-21 target, PTEN, also inhibited tumor angiogenesis by partially inactivating AKT and ERK and decreasing the expression
of HIF-1 and VEGF. The AKT and ERK inhibitors, LY294002 and U0126, suppressed HIF-1a and VEGF expression and
angiogenesis. Moreover, inhibition of HIF-1a expression alone abolished miR-21-inducing tumor angiogenesis, indicating
that HIF-1a is required for miR-21-upregulated angiogenesis. Therefore, we demonstrate that miR-21 induces tumor
angiogenesis through targeting PTEN, leading to activate AKT and ERK1/2 signaling pathways, and thereby enhancing HIF1a and VEGF expression; HIF-1a is a key downstream target of miR-21 in regulating tumor angiogenesis.
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pressed both cell growth of breast cancer in vitro and tumor growth
in the xenograft model partially through downregulating of the
antiapoptotic factor, B-cell lymphoma 2 (Bcl-2) [12]. These data,
taken together, support an important role of altered miR-21
expression during tumor development.
Tumor angiogenesis is the process that new vessels sprout from
preexisting blood vessels [13]. Angiogenesis is critical for tumor
growth and metastasis because tumor will not grow more than 1-2
mm without nutrition and oxygen [14]. Tumor angiogenesis can
be triggered by extracellular signals such as growth factors, by
genetic alterations such as activation of oncogenes, and by
mutations of tumor suppressor genes such as PTEN and p53
[15,16]. There is limited information about the relationship
between miRNA clusters and tumor angiogenesis. Several
examples are: miR-17-92 which is upregulated in colonocytes
coexpressing K-Ras and c-Myc, represses the expression of antiangiogenic thrombospondin-1 (Tsp1) and connective tissue growth
factor (CTGF), thus induces angiogenesis [17]; miR-378 promotes
angiogenesis induced by human glioblastoma cell line U87 by
targeting Fus-1 expression [18]; miR-126 regulates vascular
integrity and angiogenesis, and miR-126 restoration decreases
VEGF level in lung cancer cells [19,20]; miR-130a mediates
angiogenesis through downregulating antiangiogenic homeobox

Introduction
MicroRNAs (miRNAs) are a family of small non-coding RNAs
with the length of 21- to 25-nucleotides that regulate the
expression of various kinds of cellular proteins by targeting their
mRNA expression levels. miRNAs act as gene regulators through
translational repression or mRNA degradation via binding of
miRNAs to target sites in the 39-untranslated regions (UTR) of
protein-coding transcripts. Approximately 500 miRNA genes have
been identified in the human genome, which are involved in
regulating development, differentiation, apoptosis and proliferation [1,2]. Among these miRNAs, miR-21 is one of the well
characterized miRNAs and overexpressed in various solid tumors
including prostate cancers [3]. Recent studies indicated that
several tumor suppressors including phosphatase and tensin
homolog deleted on chromosome ten (PTEN) [4], tumor
suppressor gene tropomyosin 1 [5], programmed cell death 4
[6,7], maspin [8], and matrix metalloproteinases inhibitors RECK
and TIMP3 [9] were targets of miR-21, suggesting that miR-21 is
an important oncogenic miRNA which is closely related to tumor
growth and metastasis. The expression of miR-21 is also associated
with prognosis and the chemosensitivity and therapeutic outcome
in colon adenocarcinoma [10,11]. Moreover, anti-miR-21 supPLoS ONE | www.plosone.org
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genes GAX and HOXA5 [21]; miR-296 level is elevated in
primary brain tumor endothelial cells and regulates angiogenesis
by directly targeting the hepatocyte growth factor-regulated
tyrosine kinase substrate mRNA, leading to the reduction of
HGS-mediated degradation of the growth factor receptors
VEGFR2 and PDGFRbeta [22]. Another recent study has shown
that the two RNAse III endonucleases dicer and drosha inhibit the
expression of thrombospondin-1 by controlling the levels of let-7
and miR-27b, thus modulating angiogenesis [23]. However, the
role of miR-21 in regulating angiogenesis remains to be elucidated.
In this study, we want to study: 1) whether miR-21 regulates
hypoxia inducible factor-1 (HIF-1) and vascular endothelial
growth factor (VEGF) expression; 2) whether miR-21 regulates
tumor angiogenesis in prostate cancer cells; 3) the signaling
molecules and pathways that are regulated by miR-21 for
mediating HIF-1 and VEGF expression; and 4) whether HIF-1
is the miR-21 target for regulating tumor angiogenesis.

H2O. The incubation condition was 37uC for 30 min, followed by
95uC for 10 min. The RT products were put on the ice for realtime PCR. Real-time reaction mixtures contained 12.5 mL of
Master Mix, 0.5 mL of miR-21 primers, 2 mL of H2O, and 10 mL
of RT products above. The program is 95uC for 30 min, followed
by 40 cycles of 95uC for 15 s, and 60uC for 30 s. The expression of
U6 was used as endogenous control for each sample. The relative
gene expression was calculated by comparing cycle times for target
PCR using the following equation: relative gene expression =
22(DCtsample2DCtcontrol).

RT-PCR
Cells were cultured in 6-well plate. Total RNAs were isolated
with TRIzol reagent (Invitrogen, Carlsbad, CA) as described by
the manufacturer. Two micrograms of RNA were used for cDNA
synthesis using oligo(dT)18 as primer and M-MLV reverse
transcriptase. Aliquots of cDNA were used to detect specific
signals of VEGF by PCR using primers specific for VEGF, and for
GAPDH (an internal control) as previously described [24]. The
primers are designed using the untranslated sequences at 59 and 39
region as follows:
GAPDH sense primer, 59- CCACCCATGGCAAATTCCATGGCA-39;
GAPDH antisense primer, 59-TCTAGACGGCAGGTCAGGTCCACC-39;
VEGF sense primer, 59-TCGGGCCTCCGAAACCATGA-39;
VEGF antisense primer, 59-CCTGGTGAGAGATCTGGTTC-39.
VEGF and GAPDH were amplified by PCR for 30 cycles in a
DNA Thermal Cycler (ABI, Foster City, CA) with each cycle at
95uC for 1 min, 59uC for 30 sec, and 72uC for 1 min. PCR
products were separated on 1.2% agarose gels, stained with
ethidium bromide, and visualized under UV light. The relative
VEGF mRNA levels were normalized to those of GAPDH mRNA
using Quality One analysis software (Bio-Rad, USA).

Materials and Methods
Materials
Antibodies against HIF-1a and HIF-1b were from BD
Biosciences (Bedford, MA, USA). Antibodies against PTEN,
phospho-ERK1/2, phospho-AKT (Ser-473), and total AKT were
products of Cell Signaling Technology (Beverly, MA). Antibodies
against ERK2 were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Pre-miR-21 and negative control
precursor miRNA, anti-miR-21 inhibitor and the negative control
of anti-miRNA inhibitor were purchased from Ambion (Foster
City, CA). LY294002, U0126, and b-actin antibody were from
Sigma (St. Louis, MO). High Capacity RNA-to cDNA Kit and
Power SYBR Green PCR Master Mix were from Applied
Biosystems (Carlsbad, CA).

Cell Culture
The human prostate cancer DU145 cell was maintained in
RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS), 100 units/mL
penicillin, and 100 mg/mL streptomycin; and cultured at 37uC
in a 5% CO2 incubator. Trypsin (0.25%) solution was used to
detach the cells from the culture flask.

Real-time RT-PCR for VEGF
Cells were treated as indicated and total RNAs were extracted.
Reverse transcription reactions were performed by using High
Capacity RNA-to cDNA Kit according to the manufacturer’s
instructions. The 100 ng of RT product was used for PCR
reaction using Power SYBR Green PCR Master Mix. The
reaction contained: 10 mL of 26 PCR Master Mix, 1 mL of
forward primer, 1 mL of reverse primer, 1 mL of cDNA template,
and 7 mL of H2O. The program is 95uC for 10 min, followed by
40 cycles of 95uC for 15 s, and 60uC for 30 s, and the melt curve
was included. The primers of VEGF are: forward primer, 59CGAGGGCCTGGAGTGTG-39, reverse primer, 59-CCGCATAATCT GCATGGTGAT-39. The primers of GAPDH are:
forward primer, 59-ATGGGTGTGAACCATGA GAAGTATG39, reverse primer: 59-GGTGCAGGAGGCATTGCT-39.

MiRNA and Transient Transfection
To alter miR-21 levels in prostate cancer cells, DU145 cells
were cultured to 50–60% confluence, and transfected with the premiR-21, the negative control precursor miRNA, anti-miR-21
inhibitor, and the negative control of anti-miRNA inhibitor
(Ambion, Forster City, CA) using X-tremeGENE transfecting
reagent (Roche Applied Science, Indianapolis, IN) in serum-free
Opti-MEM medium according to the manufacturer’s instruction.
The final concentration of the oligomers was 25 nM. The cells
were switched to fresh medium containing 10% FBS after the
transfection, and cultured for 36 h. The specific protein expression
was analyzed in the cells by immunoblotting, and levels of mRNA
expression in the cells were analyzed by RT-PCR.

Angiogenesis Assay on Chicken Chorioallantoic
Membrane (CAM)
Fertilized chicken eggs were purchased from SPAFAS (Preston,
CT), and incubated at 37uC with 70% humidity for 8 days. An
artificial air sac was created, and a small window was cut in the
shell over the artificial air sac as we described [25]. Cells
transfected with pre-miR-21, pre-miRNA negative control, antimiR-21 inhibitor, or negative control miRNA inhibitor were
resuspended in serum-free medium, and mixed with equal volume
of Matrigel (BD Biosciences, Bedford, MA). Aliquots (36106 cells,
30 mL) of the mixture were then applied onto the CAM of 9-day-

Quantitative RT-PCR for MiR-21
Cells were transfected with pre-miR-21, miR-21 inhibitor or
their control oligomers. After 48 h, total RNA was extracted.
Reverse transcription reactions were performed by using mirVana
qRT-PCR miRNA Detection Kit and hsa-miR-21 qRT-PCR
primer set from Ambion. The 10 mL of reaction contained: 2 mL
of mirVana 56 RT buffer, 1 mL of miR-21 RT primer, 0.4 mL of
ArrayScript Enzyme Mix, 0.2 mL of total RNA, and 6.4 mL of
PLoS ONE | www.plosone.org
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were detected by incubating with horseradish peroxidase-conjugated antibodies and a chemiluminescence reagent (Pierce
Biotechnology, Rockford, IL).

old embryos. The area around the implanted Matrigel was
photographed 4 days after the implantation, and the number of
blood vessels was obtained by counting the branching of blood
vessels. Assays for each treatment were carried out using 8–10
chicken embryos.

Statistical Analysis
All values in the present study were reported as Mean 6 SD
from three independent experiments. Two-sided student’s unpaired t test was used for statistical analyses. P values less than .05
were considered statistically significant.

Immunoblotting
Immnoblotting was performed as described previously [26]. In
brief, cells were treated as indicated and lysed with the immune
precipitation buffer (150 mM NaCl, 100 mM Tris, pH 8.0, 1%
Triton X-100, 1% deoxycholic acid, 0.1% SDS, 5 mM EDTA,
and 10 mM NaF) supplemented with 1 mM sodium vanadate,
0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride,
2 mM leupeptin, 2 mM aprotinin, and 2 mM pepstatin on ice for
30 min. Total cellular proteins were assayed using Bio-Rad
protein assay reagent (Richmond, CA). Aliquots of the protein
extracts were resolved in SDS/polyacrylamide gels, and transferred to nitrocellulose membranes. Membranes were blocked
with 5% nonfat dry milk in 16Tris-buffered saline, and incubated
with antibodies against HIF-1a, HIF-1b, phospho-AKT, total
AKT, phospho-ERK1/2, and total ERK2. Specific protein signals

Results
MiR-21 overexpression increased HIF-1 and VEGF
expression, and induced angiogenesis
HIF-1 is a heterodimeric transcription factor, composed of two
subunits: HIF-1a and HIF-1b. HIF-1a is induced by hypoxia,
growth factors, and oncogenes; whereas HIF-1b protein is
constitutively expressed in the cells [27,28]. In most kinds of
human cancers, HIF-1 activity is increased due to the genetic
alterations or/and intratumoral hypoxia. To test whether miR-21
overexpression affects HIF-1 expression, prostate cancer cells

Figure 1. MicroRNA miR-21 overexpression increased HIF-1a and VEGF expression and induced tumor angiogenesis. (A) Human
prostate cancer cells DU145 were transfected with pre-miRNA negative control or pre-miR-21 at 25 nM. After the transfection for 36 h, cells were
collected and subjected to qRT-PCR for miR-21 expression. (B) DU145 cells were treated as in A, the total protein was extracted and subjected to
Western blotting assay. (C–D) DU145 cells were collected after the transfection for 36 h. Total RNAs were extracted and analyzed for VEGF and
GAPDH mRNA expression by RT-PCR analysis (C), and by real-time RT-PCR (D). (E) DU145 cells were transfected as above. After 24 h, cells (26106cells,
15 ml) were mixed with 15 ml Matrigel. The cell mixture was implanted onto the CAM of a 9-day old chicken embryo. After 4 days of implantation, the
CAM was cut off, and the amount of blood vessels on the CAM induced by the DU145 plugs was determined from eight different replicated
experiments. Representative plugs from negative control and miR-21 treatment groups were shown. Scale, 2 mm. (F) The number of blood vessels
were counted from replicate experiments, and normalized to that of the negative control group as relative angiogenesis. The data are mean6SD
from 6 replicates. ** indicates the significant increase when compared to the pre-miRNA negative control (p,0.01).
doi:10.1371/journal.pone.0019139.g001
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we expected, the number of branches of microvessels in the premiR-21-transfected cells increased to 3.5-fold of the control
(Figs. 1E and F). These results suggest that miR-21 induces tumor
angiogenesis by upregulating the expression of HIF-1a and
VEGF.

DU145, the PTEN wild type cells, were transfected with Pre-miR21 or negative control precursor miRNA. The expression of miR21 increased to 37-fold after pre-miR-21 transfection when
compared to the negative control, indicating that transfection of
pre-miR-21 increased mature miR-21 expression (Fig. 1A).
Consistent with previous study, overexpression of miR-21
suppressed PTEN expression [4]. We found that overexpression
of miR-21 strongly increased expression of HIF-1a, but not HIF1b (Fig. 1B). Vascular endothelial growth factor (VEGF) is one of
the important downstream targets of HIF-1a and is a strong
angiogenesis inducer [29–32]. To further evaluate whether the
increase of miR-21 also increased VEGF expression at mRNA
level, the expression of VEGF and GAPDH was tested by semiquantitative RT-PCR and real-time RT-PCR. As shown in
Figs. 1C and D, cells transfected with pre-miR-21 had 1.6-fold
mRNA level of VEGF compared with cells transfected with
negative control precursor miRNA. Given the crucial role of HIF1a and VEGF in regulating tumor angiogenesis, we hypothesized
that miR-21 can induce angiogenesis. To test our hypothesis,
human prostate cancer cell DU145 was transfected with pre-miR21 or pre-miRNA negative control. After the transfection for 24 h,
the cells were mixed with Matrigel, and implanted onto the CAM
of a 9-day old chicken embryo to perform angiogenesis assay. As

MiR-21 inhibitor decreased miR-21-inducing HIF-1 and
VEGF expression, and inhibited tumor angiogenesis
To further test the role of miR-21 in regulating tumor
angiogenesis, we overexpressed miR-21 inhibitor, which is
chemically modified, single stranded nucleic acids designed to
specifically bind to and inhibit endogenous miR-21 molecules. To
determine whether it can inhibit tumor angiogenesis and the
expression of HIF-1 and VEGF by blocking AKT and ERK1/2
pathways, DU145 cells were transfected with anti-miR-21
inhibitor and the negative control of miRNA inhibitor. When
compared to the negative control of miRNA inhibitor, transfection
with anti-miR-21 inhibitor increased PTEN expression, demonstrating that miR-21 inhibitor affects miR-21 direct target
expression in DU145 cells (Fig. 2A). The miR-21 inhibitor
treatment decreased the endogenous AKT and ERK activation,
and HIF-1a but not HIF-1b expression in the cells (Fig. 2A). The
anti-miR-21 inhibitor also decreased VEGF expression to 66%

Figure 2. The inhibitor of miR-21 inhibited miR-21-inducing expression of HIF-1a and VEGF, activation of AKT and ERK1/2, and
angiogenesis. (A) The total proteins were prepared 36 h after transfection, and analyzed by immunoblotting for the expression of PTEN, b-actin, pAKT, AKT, p-ERK1/2, ERK2, HIF-1a, and HIF-1b. (B–C) The expression levels of VEGF in the cells described as above were analyzed by RT-PCR (B), and by
real-time RT-PCR (C). (D) The cells above were used for angiogenesis assay. Representative plugs from the negative control and miR-21 inhibitor
treated groups were shown. Scale, 2 mm. (E) The number of blood vessels were counted from replicate experiments, and normalized to that of the
control group as relative angiogenesis. The data are the mean 6SD from 6 replicate experiments. ##, indicates the significant decrease when
compared to that of the control (p,0.01).
doi:10.1371/journal.pone.0019139.g002

PLoS ONE | www.plosone.org

4

April 2011 | Volume 6 | Issue 4 | e19139

MiR-21 Induced Angiogenesis by AKT, ERK, and HIF-1

negative control precursor miRNA group versus Ad-GFP+premiR-21 group: 100%69.24% versus 176%612.01%, n = 6); overepression of PTEN by adenovirus decreased miR-21-induced
angiogenesis (Ad-GFP+pre-miR-21 group versus Ad-PTEN+premiR-21 group: 176%612.01% versus 103.71%622.1%, n = 6).
The results suggest that PTEN mediates miR-21-induced tumor
angiogenesis in CAM model (Figs. 3A and 3B).

(Figs. 2B and C), and significantly inhibited the angiogenesis
responses induced by DU145 cells (Figs. 2D and E). These results
further confirm that the downregulation of miR-21 inhibits AKT
and ERK activation, and HIF-1 and VEGF expression; then
inhibits miR-21-inducing angiogenesis, demonstrating the vital
role of miR-21 in inducing tumor angiogenesis.

MiR-21 targeted PTEN in inhibiting tumor angiogenesis
MiR-21 increased HIF-1 and VEGF expression through
AKT and ERK1/2 pathways

Recent study has demonstrated that miR-21 increased cell
proliferation, migration and invasion through modulating tumorsuppressor gene PTEN (4), but the role of PTEN in miR-21
inducing tumor angiogenesis remains to be elucidated. PTEN is an
antagonist of phosphatidylinotidol 3-kinase (PI3K) by removing
the 39 phosphate of phosphatidylinositol 3,4,5-trisphosphate
(PIP3). PTEN also inhibits the activation of mitogen-activated
protein kinase (MAPK), which is the upstream regulator of ERK
[33,34]. To determine whether overexpression PTEN can inhibit
miR-21 inducing prostate tumnor angiogenesis, DU145 cells were
infected with adenoviruses carrying GFP or PTEN (Ad-PTEN).
After 24 h, cells were transfected with pre-miR-21 or negative
control precursor miRNA, and angiogenesis assay was performed
as described above. Consistent with that PTEN is one of the miR21 targets, miR-21 induced tumor angiogenesis (Ad-GFP+

AKT (also known as protein kinase B) and extracellular signal
regulated kinase (ERK) are two major signaling pathways in
regulating cell proliferation, migration, and survival through its
downstream targets including HIF-1a [35-38]. To determine the
signaling molecules that are involved in miR-21-inducing HIF-1a
and VEGF expression and angiogenesis, we found that overexpression of miR-21 induced AKT and ERK1/2 activation when
compared to the negative control of precursor miRNA group by
Western blotting (Fig. 4A). To further study the role of AKT and
ERK in regulating HIF-1a and VEGF expression, DU145 cells
were transfected with pre-miR-21 and treated with the inhibitors
of AKT and ERK1/2, LY294002 and U0126 at 10 mM,
respectively. LY294002 treatment abolished miR-21-inducing

Figure 3. PTEN was the downstream target of miR-21 in inducing angiogenesis. (A) DU145 cells were infected with adenovirus carrying
GFP (Ad-GFP) or PTEN (Ad-PTEN). After 24 h, cells were transfected with pre-miR-21 or scrambled control. The next day, cells were trypsinized and
angiogenesis assay was performed as above. The representative plugs from treatments of Ad-GFP plus scrambled control, Ad-GFP plus pre-miR-21,
and Ad-PTEN plus pre-miR-21 were shown in the picture. Scale, 2 mm. (B) The relative angiogenesis was showed in the bar graph. Results from each
group are presented as mean 6SD of 6 samples. * indicates the significant increase when compared to the Ad-GFP plus scrambled control group
(p,0.05). #, indicates the significant decrease when compared to Ad-GFP plus miR-21 group (p,0.05).
doi:10.1371/journal.pone.0019139.g003
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Figure 4. miR-21 induced the activation of AKT and ERK1/2, and the expression of HIF-1a and VEGF. (A) DU145 cells were seeded into
60 mm dishes. When cells were 60% confluence, cells were transfected with pre-miRNA negative control or pre-miR-21 as described above. Total
proteins were extracted 36 h after the transfection, and analyzed for the expression of phospho-AKT (p-AKT), total AKT, phospho-ERK1/2 (p-ERK), and
ERK2 by immunoblotting. (B) DU145 cells were transfected with pre-miR-21 precursor as described above. After the transfection for 36 h, the cells
were treated with solvent alone, 10 mM of LY294002, or 10 mM of U0126 for 6 h. The expression levels of p-AKT, total AKT, p-ERK, ERK2, HIF-1a and
HIF-1b were analyzed by immunoblotting. (C-D) After the transfection of cells with pre-miR-21, the cells were cultured for 36 h, then treated with
solvent alone, 10 mM of LY294002, or 10 mM of U0126 for 12 h. VEGF mRNA expression was analyzed by RT-PCR (C), and by real-time RT-PCR (D). ##,
indicates the significant decrease when compared to that of the control (p,0.01).
doi:10.1371/journal.pone.0019139.g004

angiogenesis assay as above. Immunoblotting reslults showed that
Ad-siHIF-1a infection greatly blocked HIF-1a expression when
compared to the Ad-GFP treatment at protein level, but did not
affect AKT and ERK1/2 activation (Fig. 6A), confirming that
HIF-1a is the downstream molecule of AKT and ERK. Consistent
with previous study showing that HIF-1a is the regulator of
VEGF, HIF-1a siRNA also decreased miR-21-inducing VEGF
mRNA expression in the cells (Fig. 6B). To further test whether the
knockdown of HIF-1a is sufficient to decrease miR-21-inducing
angiogenesis, the cells infected by the adenoviruses carrying
scrambled siRNA and HIF-1a siRNA at 20 MOI were used for
the angiogenesis assay in the CAM. As shown in Figs. 6C and D,
the infection of DU145 cells by Ad-siHIF-1a decreased miR-21inducing angiogenesis to 40% of the control group. These results
suggest that upregulation of HIF-1a expression is necessary for
miR-21 to induce tumor angiogenesis.
Taken together, our studies demonstrate that: 1) miR-21 upregulated HIF-1a and VEGF expression and induced angiogenesis
in prostate cancer cells; 2) miR-21 induced HIF-1a and VEGF
expression through targeting PTEN, thus regulating AKT and
ERK pathways; 3) both PI3K/AKT and ERK pathways are
required for miR-21-inducing angiogenesis; 4) HIF-1a is an
essential downstream effecter of miR-21 in mediating angiogenesis, and HIF-1a is regulated by miR-21 through the activation of
AKT and ERK in the cells.

AKT activation, while U0126 inhibited miR-21-inducing ERK1/
2 activation. Both LY294002 and U0126 treatment abolished
miR-21-inducing HIF-1a expression (Fig. 4B). These results are
consistent with previous reports that AKT and ERK are upstream
regulators of HIF-1a expression. Similarly, the miR-21-inducing
VEGF mRNA levels were inhibited by LY294002 and U0126 in
the cells by 44% and 53%, respectively (Figs. 4C and D).

AKT, ERK1/2, and HIF-1 are required for miR-21-inducing
angiogenesis
In previous studies, we identified that miR-21 induced HIF-1
and VEGF expression through activating AKT and ERK1/2
pathways. To assess whether AKT and ERK are required for
miR-21-inducing angiogenesis, DU145 cells were transfected with
pre-miR-21, then treated with solvent, LY294002, or U0126 to
perform the angiogenesis assay using the CAM model as before.
The miR-21-inducing angiogenesis was decreased to less than
40% when the cells were treated with 10 mM of LY294002 or
U0126 (Figs. 5A and B). These data suggest that both AKT and
ERK1/2 are required for miR-21 in inducing angiogenesis,
indicating that AKT and ERK1/2 pathways are two parallel
downstream pathways of miR-21 for regulating HIF-1a and
VEGF expression and angiogenesis.
To further determine whether HIF-1a is an essential downstream molecule in mediating miR-21-inducing angiogenesis,
DU145 cells were transfected with pre-miR-21 and cultured
overnight. Then the cells were infected with adenovirus carrying
scrambled siRNA (Ad-siSCR) or siRNA against HIF-1a (AdsiHIF-1a). After the infection, the cells were used for the
PLoS ONE | www.plosone.org
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Figure 5. miR-21 induced angiogenesis through mediating AKT and ERK1/2 activation. (A) DU145 cells were transfected with pre-miR-21.
After transfection for 36 h, the cells were trypsinized, mixed with 15 ml Matrigel in the presence or absence of 10 mM of LY294002 or U0126.
Representative plugs from DMSO control, LY294002, and U0126 treatment groups were shown. Scale, 2 mm. (B) The number of blood vessels were
counted from 8 replicate experiments, and normalized to that of the pre-miR-21 group as relative angiogenesis. ##, indicates the significant decrease
when compared to that of pre-miR-21 treatment group (p,0.01).
doi:10.1371/journal.pone.0019139.g005

Next, we want to investigate the mechanism and relative
signaling molecules in miR-21- inducing tumor angiogenesis.
Recent study indicated that miR-21 inhibited the function of tumor
suppressor PTEN expression by binding its 39 UTR [4]. PTEN is
the antagonist of phosphatidylinositol 3-kinase (PI3K), which
removes the 39 phosphate of PIP3 and attenuates signaling
molecules downstream of PI3K. PTEN is frequently mutated or
lost in many kinds of solid tumors [49]. PTEN is the upstream
regulator of both PI3K/AKT and MEK/ERK signaling pathways.
The PI3K/AKT and ERK signaling pathways play crucial roles in
various intracellular cascade events including tumor angiogenesis
and tumor growth [50,51]. In accord with previous study, PTEN
overexpression notably blocked miR-21-induced tumor angiogenesis, confirming that miR-21 exhibits its role partly by inhibiting
PTEN expression and the recovery of PTEN expression restored its
function of tumor suppressor. We also found that overexpression of
miR-21 led to the activation of AKT and ERK1/2. Treatment of
the cells with PI3K or ERK1/2 inhibitor LY294002 or U0126,
respectively, prohibited miR-21-inducing HIF-1a and VEGF
expression and angiogenesis, suggesting that both PI3K and ERK
are required for miR-21-inducing angiogenesis through the
downregulation of HIF-1a and VEGF expression. Taken together,
miR-21 inhibited PTEN expression, which in turn decreased AKT
and ERK activation for inhibiting HIF-1a and VEGF expression,
thus inducing tumor angiogenesis.
HIF-1a regulates many target genes including VEGF by
binding to their promoters [27]. Finally, given the important role

shows that miR-21 overexpression is detected in various kinds of
human cancers including prostate cancer, and is associated with
tumor metastasis [3,4,41–46], but the direct role of miR-21 in
regulating tumor angiogenesis remains to be elucidated. Angiogenesis is required for tumor growth and metastasis. VEGF plays a
key role in regulating embryonic angiogenesis and tumor
angiogenesis [47,48]. HIF-1 regulates VEGF expression through
transcriptional activation [29]. In this study, we demonstrated that
overexpression of miR-21 in human prostate cancer cells increased
the expression of HIF-1a and VEGF, and induced tumor
angiogenesis. This result demonstrated that miR-21 was sufficient
to induce angiogenesis through modulating the expression of HIF1a and VEGF, providing the direct evidence that miR-21 is able
to regulate tumor angiogenesis.
To further study the role of miR-21 in inducing prostate tumor
angiogenesis, we used the inhibitor of miR-21, which can
specifically bind to and inhibit endogenous miR-21 molecules,
or its negative control oligomer, to transfect DU145 cells. The
anti-miR-21 decreased 70% of endogenous miR-21 expression in
the cells. In consistent with the overexpression results, inhibition
of miR-21 expression in DU145 cells partially decreased AKT
and ERK1/2 activation, abolished HIF-1a expression, and
inhibited VEGF level to 50%. The relative angiogenesis was
also inhibited 50% by the anti-miR-21, indicating that miR-21
plays an important role in mediating angiogenesis through
regulating AKT and ERK activation, and HIF-1a and VEGF
expression.
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Figure 6. HIF-1a expression is required in miR-21 inducing VEGF expression and tumor angiogenesis. (A) DU145 cells were transfected
with pre-miR-21. After 24 h incubation, cells were infected with adenovirus carrying GFP (Ad-SCR) or siRNA against HIF-1a (Ad-siHIF-1a) at 20 MOI for
24 h. The total proteins were analyzed by immunoblotting. (B–C) The expression levels of VEGF and GAPDH mRNA were analyzed by RT-PCR (B), and
by real-time RT-PCR (C). (D) After DU145 cells were transfected with pre-miR-21 for 24 h, the cells were infected with Ad-GFP or Ad-siHIF-1a at 20 MOI
for 24 h. Then the cells were used to perform angiogenesis assay as described above. The picture showed the representative plugs from Ad-GFP and
Ad-siHIF-1a treatment groups. Scale, 2 mm. (E) The number of blood vessels were counted from replicate experiments, and normalized to that of the
Ad-siSCR group as relative angiogenesis. The data are mean 6 SD from 6 replicate experiments. ##, indicates the significant difference when
compared to that of the Ad-siSCR group (p,0.01).
doi:10.1371/journal.pone.0019139.g006

of HIF-1 and VEGF in mediating tumor growth and angiogenesis,
we hypothesize that HIF-1 is a downstream target required for
miR-21-inducing angiogenesis. To test this postulation, we found
that HIF-1a siRNA significantly inhibited the expression of HIF1a and VEGF and tumor angiogenesis without the change of
phospho-AKT and phospho-ERK expression. This data suggests
that HIF-1a is a key downstream target of miR-21, which is
required for inducing angiogenesis, and is downstream of both
AKT and ERK pathways in regulating miR-21-inducing angiogenesis. Taken together, our results demonstrated that miR-21
regulates tumor angiogenesis through inducing HIF-1a and VEGF
expression; activates both AKT and ERK pathways for mediating
angiogenesis. HIF-1a is an important downstream target of miR-

21, and is regulated by both AKT and ERK during miR-21inducing angiogenesis. This study shows a direct role and novel
mechanism of miR-21 in inducing angiogenesis and the
information may be useful to develop a new anti-angiogenesis
therapy for prostate cancer treatment in the future.
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